
Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain
Keywords: EP4; EP4 receptor agonist; PGE2; Prostaglandin E2 receptor 4; Pain; Arthritis; Anti-inflammatory; Anti-hyperalgesic; Neuropathic pain;